MarketPeel
Pricing
…
Chief R&D Officer
Bahram Valamehr
Thu, Jan 12, 2023
Jan 12
exercised or converted securities in FATE
423 shares @ $1.37
Increased holdings by +0.30%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
FATEFATE THERAPEUTICS INC
HealthcareBiotechnology
1D0.00%
1W-6.49%
1M+1.66%
3M+13.95%
6M—
1Y—

Recent insider activity at FATE

Aug 4Bahram ValamehrSold$108.10kAug 4Cindy TahlSold$95.41kMay 20Bahram ValamehrSold$54.48kMay 20Cindy TahlSold$48.08kJan 9Cindy TahlSold$11.28kJan 9Bahram ValamehrSold$5.56kAug 4Cindy TahlSold$9.57kAug 4Bahram ValamehrSold$15.40k
Full FATE profile →Bahram Valamehr’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback